Casdin Capital, LLC Cytom X Therapeutics, Inc. Transaction History

Casdin Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$12.69 - $18.61 $2.63 Million - $3.86 Million	-207,500 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$21.76 - $34.22 $652,800 - $1.03 Million	30,000 Added 16.9%	207,500 $5.9 Million
Q3 2017 Nov 14, 2017	BUY	$13.53 - $18.17 $2.4 Million - $3.23 Million	177,500	177,500 $3.23 Million

49.4M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $55.4M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Casdin Capital, LLC with notifications on news.